Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $32.00 Consensus Target Price from Brokerages

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been given a consensus recommendation of “Moderate Buy” by the five brokerages that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $32.00.

Several analysts have recently weighed in on the stock. Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research note on Friday, November 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Stephens raised their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Finally, Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 17th.

Institutional Trading of Guardian Pharmacy Services

Several large investors have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd acquired a new position in Guardian Pharmacy Services during the 1st quarter worth approximately $233,000. Envestnet Asset Management Inc. grew its stake in Guardian Pharmacy Services by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after acquiring an additional 805 shares during the period. Los Angeles Capital Management LLC bought a new stake in shares of Guardian Pharmacy Services during the second quarter valued at approximately $311,000. Parkside Financial Bank & Trust bought a new stake in shares of Guardian Pharmacy Services during the second quarter valued at approximately $41,000. Finally, CSM Advisors LLC acquired a new position in shares of Guardian Pharmacy Services during the second quarter worth approximately $2,052,000.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock opened at $31.88 on Thursday. The stock has a market cap of $2.02 billion, a PE ratio of 50.60 and a beta of 0.86. Guardian Pharmacy Services has a 52-week low of $17.78 and a 52-week high of $37.43. The firm has a 50-day moving average of $31.63 and a 200-day moving average of $29.17.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.